Please login to the form below

Not currently logged in
Email:
Password:

Glide Pharma appoints Mark Carnegie-Brown as CEO

Was formerly CEO of Evolutec and Aenova

Glide Pharma Mark Carnegie-BrownDr Mark Carnegie-Brown has joined Glide Pharma as CEO.

He brings more than 25 years of experience in the healthcare and life sciences industry to Glide - a development and device company focused on the needle-free administration of solid dose formulations.

His past experience includes five years as CEO of protein drug development company Evolutec from 2003 to 2008 and a year as CEO of contract manufacturing organisation Aenova from 2008 to 2009.

He also served as UK and Northern Europe managing director at Elsevier Health Sciences from 2009 to 2011 and managing director of Carbon Fibre Technologies International from November 2011.

“His research and commercial experience, and in particular his expertise in building successful clinical and manufacturing programmes, will prove invaluable as Glide scales up its capabilities and advances the development of its in-house programmes,” said Mark Kirby, chairman of Glide Pharma.

8th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics